Drug Trial Radar · NCT04359680
Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection
Last checked: Nov 20, 2026Latest source record: Jun 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,407
Actual
Start
May 13, 2020
Primary completion
Apr 7, 2021
Study completion Apr 7, 2021
Sponsor
- Lead sponsor
- Romark Laboratories L.C.Industry
- Sponsor type
- Industry
- First posted
- Apr 24, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 120 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection
Conditions
- COVID-19
- Viral Respiratory Illnesses
Interventions
NitazoxanideDrug
Nitazoxanide 600 mg administered orally twice daily for six weeks
PlaceboDrug
Placebo administered orally twice daily for six weeks
Vitamin Super B-ComplexDietary supplement
Vitamin Super B-Complex administered orally twice daily to maintain the blind
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Proportion of Subjects With Symptomatic Laboratory-confirmed COVID-19 Identified After Start of Treatment and Before the End of the 6-week Treatment Period.Time frame: Up to 6 weeks
- The Proportion of Subjects With Symptomatic Laboratory-confirmed VRI Identified After the Start of Treatment and Before the End of the 6-week Treatment Period.Time frame: Up to 6 weeks
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
HealthStar Research LLC
Hot Springs, Arkansas
So Cal Clinical Research
Huntington Beach, California
Long Beach Clinical Trials, LLC
Long Beach, California
Meris Clinical Research
Brandon, Florida
Invesclinica US LLC
Fort Lauderdale, Florida
The Chappel Group Research
Kissimmee, Florida
New Horizon Research Center
Miami, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
DMI Research
Pinellas Park, Florida
Tampa General Hospital
Tampa, Florida
Chicago Clinical Research Institute, Inc.
Chicago, Illinois
Chicago Medical Research Institute, Inc.
Chicago, Illinois
Quad Clinical Research
Chicago, Illinois
Chicago Medical Research, LLC
Hazel Crest, Illinois
Centex Studies, Inc.
Lake Charles, Louisiana
Vida Clinical Studies
Dearborn, Michigan
Beacom Family Health Connection
Fremont, Nebraska
North Jersey Community Research Initiative
Newark, New Jersey
Integrative Clinical Trials LLC
Brooklyn, New York
The New York Center for Travel and Tropical Medicine
New York, New York
RH Medical Urgent Care Professional PLLC
The Bronx, New York
Centex Studies, Inc.
Houston, Texas
SMS Clinical Research LLC
Mesquite, Texas
LinQ Research LLC
Pearland, Texas
Rio Grande Valley Clinical Research Institute
Pharr, Texas
BFHC Research
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.